Noxxon Supervisory Board Elects Experienced US & EU Biotech Veteran Don deBethizy Chairman
NOXXON Pharma N.V. (EuroNext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by tar…
NOXXON Pharma N.V. (EuroNext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by tar…
- International consortium of investors led by TVM Capital Life Science together with DPE Deutsche Private Equity, Carev…
NOXXON Pharma N.V. (Alternext Paris: ALNOX), a biotechnology company whose core focus is on cancer treatment, has today…
TVM Life Science Ventures VII today announced the fund's third investment - GLWL Research Inc., a company based in Montr…
. - Driving innovation and capital efficiency with strong liquidity position - Positive news flow characterises third…
During BioEurope 2013 in Vienna, TVM Capital, who has long been a leading international investment firm, announced that…
. - Biotechnology Value Fund, L.P. and other affiliates of US Investment firm BVF Partners L.P. ('BVF') invest EUR 30 m…
Enso Holding Limited is pleased to announce the immediate appointment of Mr. Ewald Braith as its General Manager respons…
DIREVO Biotech AG, a leading company for superior bioengineered products and processes for industrial and pharmaceutical…
DIREVO Biotech AG, a leading company for superior bioengineered products and processes for industrial and pharmaceutical…